This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
immune | response | 534 |
present | study | 461 |
- | cell | 437 |
- | time | 415 |
- | elisa | 286 |
immune | responses | 250 |
inflammatory | response | 213 |
- | test | 195 |
specific | antibodies | 188 |
- | cells | 184 |
high | levels | 162 |
first | time | 161 |
healthy | controls | 161 |
positive | results | 150 |
negative | control | 147 |
- | treatment | 134 |
- | evs | 118 |
positive | samples | 115 |
- | protein | 114 |
- | infection | 113 |
positive | control | 113 |
- | assay | 109 |
immune | cells | 109 |
human | serum | 100 |
specific | antibody | 97 |
higher | levels | 89 |
clinical | samples | 87 |
viral | infections | 86 |
total | protein | 85 |
negative | controls | 83 |
inflammatory | responses | 77 |
- | expression | 76 |
inflammatory | diseases | 75 |
similar | results | 73 |
- | controlled | 72 |
- | mouse | 72 |
positive | serum | 72 |
high | level | 71 |
viral | infection | 67 |
severe | disease | 66 |
low | levels | 63 |
- | analysis | 61 |
- | level | 61 |
respiratory | disease | 60 |
negative | results | 59 |
negative | serum | 56 |
- | ev | 55 |
clinical | studies | 55 |
positive | cells | 55 |
healthy | control | 54 |
clinical | disease | 54 |
viral | proteins | 52 |
- | day | 51 |
negative | samples | 51 |
- | group | 50 |
presenting | cells | 50 |
- | antibody | 49 |
- | control | 49 |
- | response | 45 |
inflammatory | cells | 44 |
positive | result | 44 |
respiratory | infections | 44 |
first | study | 43 |
respiratory | viruses | 41 |
other | groups | 41 |
immune | cell | 40 |
different | cell | 39 |
different | time | 38 |
low | level | 38 |
human | cells | 37 |
viral | diseases | 37 |
- | tests | 36 |
other | studies | 36 |
positive | test | 36 |
total | antibody | 36 |
significant | effect | 35 |
lower | levels | 35 |
other | viruses | 35 |
positive | elisa | 33 |
clinical | response | 31 |
human | disease | 31 |
- | antibodies | 29 |
- | patients | 29 |
positive | patients | 29 |
clinical | study | 28 |
positive | controls | 28 |
viral | protein | 28 |
specific | elisa | 27 |
inflammatory | disease | 27 |
- | p | 27 |
inflammatory | effect | 26 |
inflammatory | effects | 26 |
normal | controls | 26 |
respiratory | diseases | 26 |
- | virus | 25 |
other | proteins | 25 |
different | methods | 24 |
different | times | 24 |
human | infection | 24 |
high | expression | 23 |
- | gene | 23 |
normal | levels | 22 |
viral | disease | 22 |
other | cells | 22 |
acute | infection | 21 |
different | groups | 21 |
first | day | 21 |
higher | expression | 21 |
negative | result | 21 |
severe | infections | 21 |
high | serum | 20 |
inflammatory | cell | 20 |
normal | serum | 20 |
normal | cells | 19 |
total | serum | 19 |
positive | sample | 19 |
highest | level | 19 |
molecular | methods | 19 |
acute | disease | 19 |
first | group | 18 |
human | diseases | 18 |
molecular | level | 18 |
other | methods | 18 |
specific | proteins | 18 |
other | cell | 17 |
total | evs | 17 |
respiratory | infection | 17 |
other | tests | 17 |
human | samples | 17 |
low | serum | 17 |
different | levels | 17 |
different | ev | 17 |
high | antibody | 16 |
normal | control | 16 |
specific | protein | 16 |
specific | serum | 16 |
other | group | 15 |
specific | cell | 15 |
positive | response | 15 |
positive | effect | 15 |
other | patients | 15 |
other | diseases | 15 |
lower | level | 15 |
higher | level | 15 |
first | results | 15 |
different | proteins | 15 |
human | cell | 14 |
respiratory | virus | 14 |
other | genes | 14 |
new | virus | 14 |
new | method | 14 |
negative | patients | 14 |
clinical | serum | 14 |
high | protein | 14 |
- | levels | 14 |
- | infections | 14 |
different | days | 14 |
- | patient | 14 |
early | infection | 13 |
similar | levels | 13 |
similar | effects | 13 |
- | disease | 13 |
present | results | 13 |
clinical | sample | 13 |
clinical | analysis | 13 |
- | serum | 13 |
- | effect | 13 |
earlier | studies | 13 |
lower | expression | 12 |
total | antibodies | 12 |
specific | genes | 12 |
positive | antibody | 12 |
other | samples | 12 |
normal | mice | 12 |
new | assay | 12 |
human | patients | 12 |
highest | levels | 12 |
first | days | 12 |
different | serum | 12 |
- | proteins | 12 |
- | effects | 12 |
total | proteins | 11 |
total | cell | 11 |
such | antibodies | 11 |
significant | effects | 11 |
new | treatment | 11 |
inflammatory | genes | 11 |
immune | serum | 11 |
highest | serum | 11 |
first | patient | 11 |
- | study | 11 |
- | days | 11 |
molecular | assays | 10 |
specific | test | 10 |
significant | levels | 10 |
presented | study | 10 |
other | assays | 10 |
negative | effect | 10 |
human | antibodies | 10 |
higher | antibody | 10 |
different | studies | 10 |
different | expression | 10 |
different | disease | 10 |
different | assays | 10 |
lower | serum | 9 |
specific | treatment | 9 |
specific | evs | 9 |
presenting | cell | 9 |
positive | effects | 9 |
other | day | 9 |
other | antibodies | 9 |
molecular | analysis | 9 |
molecular | method | 9 |
low | expression | 9 |
clinical | responses | 9 |
human | studies | 9 |
- | sample | 9 |
clinical | effects | 9 |
- | genes | 9 |
different | diseases | 9 |
early | treatment | 9 |
human | infections | 9 |
other | virus | 8 |
viral | antibodies | 8 |
specific | gene | 8 |
specific | cells | 8 |
severe | group | 8 |
respiratory | samples | 8 |
positive | tests | 8 |
positive | responses | 8 |
positive | evs | 8 |
- | method | 8 |
normal | mouse | 8 |
low | protein | 8 |
inflammatory | protein | 8 |
healthy | patients | 8 |
early | disease | 8 |
different | virus | 8 |
different | antibodies | 8 |
- | groups | 8 |
negative | sample | 7 |
such | patients | 7 |
specific | expression | 7 |
specific | ev | 7 |
specific | assays | 7 |
normal | samples | 7 |
negative | tests | 7 |
negative | test | 7 |
higher | serum | 7 |
higher | protein | 7 |
healthy | mice | 7 |
different | protein | 7 |
different | cells | 7 |
- | responses | 7 |
human | proteins | 7 |
negative | group | 6 |
new | treatments | 6 |
lower | antibody | 6 |
negative | cell | 6 |
negative | infections | 6 |
such | infections | 6 |
other | infections | 6 |
significant | response | 6 |
specific | responses | 6 |
human | gene | 6 |
total | study | 6 |
inflammatory | gene | 6 |
human | antibody | 6 |
clinical | infection | 6 |
healthy | group | 6 |
early | time | 6 |
earlier | time | 6 |
earlier | study | 6 |
different | viruses | 6 |
different | samples | 6 |
different | genes | 6 |
different | elisa | 6 |
highest | antibody | 6 |
clinical | effect | 6 |
acute | infections | 6 |
- | assays | 6 |
positive | cell | 5 |
present | time | 5 |
present | studies | 5 |
significant | expression | 5 |
other | tested | 5 |
other | study | 5 |
other | patient | 5 |
severe | infection | 5 |
other | disease | 5 |
significant | level | 5 |
significant | results | 5 |
specific | effect | 5 |
such | cells | 5 |
such | studies | 5 |
total | cells | 5 |
total | group | 5 |
molecular | tests | 5 |
high | cells | 5 |
new | methods | 5 |
- | results | 5 |
- | tested | 5 |
clinical | treatment | 5 |
different | effects | 5 |
different | patients | 5 |
different | results | 5 |
first | treatment | 5 |
molecular | studies | 5 |
higher | virus | 5 |
human | virus | 5 |
immune | control | 5 |
low | antibody | 5 |
low | sample | 5 |
molecular | levels | 5 |
highest | expression | 5 |
respiratory | sample | 4 |
significant | genes | 4 |
significant | antibody | 4 |
severe | days | 4 |
normal | level | 4 |
positive | infections | 4 |
positive | group | 4 |
similar | expression | 4 |
normal | cell | 4 |
new | elisa | 4 |
similar | effect | 4 |
specific | diseases | 4 |
similar | methods | 4 |
similar | study | 4 |
specific | assay | 4 |
specific | group | 4 |
specific | method | 4 |
specific | response | 4 |
negative | responses | 4 |
such | samples | 4 |
such | treatment | 4 |
total | ev | 4 |
total | sample | 4 |
such | assays | 4 |
negative | response | 4 |
negative | infection | 4 |
healthy | cells | 4 |
- | mice | 4 |
- | times | 4 |
acute | response | 4 |
negative | elisa | 4 |
clinical | patients | 4 |
different | antibody | 4 |
different | response | 4 |
early | response | 4 |
early | studies | 4 |
first | sample | 4 |
clinical | expression | 4 |
high | virus | 4 |
low | virus | 4 |
higher | responses | 4 |
negative | effects | 4 |
lowest | level | 4 |
molecular | test | 4 |
low | cell | 4 |
immune | diseases | 4 |
human | genes | 4 |
human | elisa | 4 |
other | elisa | 3 |
significant | treatment | 3 |
significant | cell | 3 |
positive | antibodies | 3 |
other | serum | 3 |
other | protein | 3 |
other | ev | 3 |
normal | evs | 3 |
other | control | 3 |
other | antibody | 3 |
normal | group | 3 |
similar | disease | 3 |
new | genes | 3 |
new | ev | 3 |
similar | antibody | 3 |
negative | cells | 3 |
similar | response | 3 |
similar | studies | 3 |
similar | virus | 3 |
specific | analysis | 3 |
specific | disease | 3 |
specific | mouse | 3 |
such | methods | 3 |
such | response | 3 |
such | study | 3 |
such | tests | 3 |
total | levels | 3 |
viral | antibody | 3 |
viral | assays | 3 |
viral | cell | 3 |
viral | gene | 3 |
new | antibodies | 3 |
inflammatory | proteins | 3 |
negative | antibody | 3 |
first | elisa | 3 |
molecular | assay | 3 |
- | analyses | 3 |
- | result | 3 |
- | treatments | 3 |
acute | patients | 3 |
clinical | results | 3 |
different | mouse | 3 |
different | patient | 3 |
different | sample | 3 |
different | tests | 3 |
different | treatment | 3 |
early | days | 3 |
early | responses | 3 |
early | samples | 3 |
- | studies | 3 |
high | disease | 3 |
important | effects | 3 |
high | elisa | 3 |
molecular | analyses | 3 |
low | cells | 3 |
important | protein | 3 |
important | group | 3 |
important | genes | 3 |
lowest | levels | 3 |
important | diseases | 3 |
high | response | 3 |
human | study | 3 |
human | protein | 3 |
human | evs | 3 |
immune | effects | 3 |
other | test | 2 |
other | time | 2 |
other | treatment | 2 |
others | groups | 2 |
positive | assay | 2 |
positive | virus | 2 |
positive | ev | 2 |
positive | patient | 2 |
positives | results | 2 |
present | elisa | 2 |
other | mouse | 2 |
presented | patients | 2 |
other | sample | 2 |
newer | methods | 2 |
other | gene | 2 |
other | effects | 2 |
other | assay | 2 |
normal | results | 2 |
normal | proteins | 2 |
normal | groups | 2 |
new | viruses | 2 |
new | test | 2 |
new | studies | 2 |
new | protein | 2 |
new | group | 2 |
severe | diseases | 2 |
respiratory | effects | 2 |
such | effect | 2 |
severe | patients | 2 |
significant | disease | 2 |
viral | samples | 2 |
viral | sample | 2 |
viral | genes | 2 |
total | treatment | 2 |
total | infection | 2 |
total | assay | 2 |
total | analysis | 2 |
such | viruses | 2 |
such | proteins | 2 |
such | evs | 2 |
such | effects | 2 |
new | disease | 2 |
specific | tests | 2 |
specific | studies | 2 |
specific | groups | 2 |
specific | effects | 2 |
similar | sample | 2 |
similar | result | 2 |
similar | responses | 2 |
similar | protein | 2 |
similar | patients | 2 |
similar | diseases | 2 |
similar | analysis | 2 |
significant | time | 2 |
significant | p | 2 |
new | diseases | 2 |
specific | virus | 2 |
new | cell | 2 |
high | treatment | 2 |
healthy | treatment | 2 |
healthy | groups | 2 |
first | test | 2 |
first | controlled | 2 |
first | assay | 2 |
early | times | 2 |
early | results | 2 |
early | mouse | 2 |
early | infections | 2 |
early | control | 2 |
different | treatments | 2 |
different | method | 2 |
different | infections | 2 |
different | gene | 2 |
different | evs | 2 |
clinical | patient | 2 |
clinical | control | 2 |
clinical | assays | 2 |
acute | ev | 2 |
- | viruses | 2 |
- | testing | 2 |
- | studied | 2 |
- | samples | 2 |
- | grouped | 2 |
new | assays | 2 |
high | assay | 2 |
different | test | 2 |
higher | elisa | 2 |
important | disease | 2 |
molecular | study | 2 |
higher | ev | 2 |
molecular | expression | 2 |
lower | protein | 2 |
lower | infection | 2 |
lower | % | 2 |
low | response | 2 |
low | p | 2 |
important | viruses | 2 |
important | virus | 2 |
important | gene | 2 |
important | effect | 2 |
low | disease | 2 |
negative | day | 2 |
human | patient | 2 |
higher | p | 2 |
higher | treatment | 2 |
highest | ev | 2 |
highest | sample | 2 |
human | group | 2 |
higher | results | 2 |
immune | assay | 2 |
immune | mice | 2 |
immune | proteins | 2 |
important | cell | 2 |
positive | expressions | 1 |
positive | mice | 1 |
positive | infection | 1 |
positive | groups | 1 |
positive | gene | 1 |
other | treatments | 1 |
positive | expression | 1 |
positive | sera | 1 |
other | times | 1 |
other | studied | 1 |
other | mice | 1 |
other | infection | 1 |
positive | proteins | 1 |
presented | assay | 1 |
positive | serums | 1 |
positive | study | 1 |
positive | treatment | 1 |
positives | cells | 1 |
positives | result | 1 |
present | analysis | 1 |
present | day | 1 |
present | days | 1 |
present | method | 1 |
present | patient | 1 |
present | test | 1 |
presented | results | 1 |
other | controls | 1 |
other | expression | 1 |
negative | study | 1 |
other | analyses | 1 |
normal | treatment | 1 |
negative | patient | 1 |
negative | protein | 1 |
presented | tests | 1 |
negative | virus | 1 |
new | antibody | 1 |
new | control | 1 |
new | expression | 1 |
new | gene | 1 |
new | infections | 1 |
new | mice | 1 |
new | mouse | 1 |
new | patient | 1 |
new | patients | 1 |
new | proteins | 1 |
new | sample | 1 |
new | tests | 1 |
newer | assays | 1 |
newer | diseases | 1 |
newer | elisa | 1 |
newer | tests | 1 |
newer | virus | 1 |
normal | ev | 1 |
normal | gene | 1 |
normal | infection | 1 |
normal | patients | 1 |
normal | response | 1 |
normal | responses | 1 |
presented | studies | 1 |
similar | treatment | 1 |
severe | day | 1 |
such | time | 1 |
specific | viruses | 1 |
such | analyses | 1 |
such | antibody | 1 |
such | cell | 1 |
such | expression | 1 |
such | infection | 1 |
such | levels | 1 |
such | method | 1 |
such | patient | 1 |
such | results | 1 |
such | sample | 1 |
such | serum | 1 |
such | virus | 1 |
specific | result | 1 |
total | control | 1 |
total | days | 1 |
total | effect | 1 |
total | infections | 1 |
total | level | 1 |
total | patient | 1 |
total | test | 1 |
total | time | 1 |
total | virus | 1 |
viral | control | 1 |
viral | effects | 1 |
negative | groups | 1 |
specific | results | 1 |
specific | infections | 1 |
severe | effects | 1 |
significant | virus | 1 |
severe | gene | 1 |
severe | groups | 1 |
severe | mouse | 1 |
severe | response | 1 |
severe | result | 1 |
significant | ev | 1 |
significant | group | 1 |
significant | infection | 1 |
significant | infections | 1 |
significant | proteins | 1 |
significant | serum | 1 |
significant | test | 1 |
similar | assay | 1 |
specific | controls | 1 |
similar | assays | 1 |
similar | cell | 1 |
similar | elisa | 1 |
similar | gene | 1 |
similar | group | 1 |
similar | patient | 1 |
similar | samples | 1 |
similar | serum | 1 |
similar | test | 1 |
similar | time | 1 |
similar | viruses | 1 |
specific | analyses | 1 |
negative | mouse | 1 |
healthy | cell | 1 |
negative | gene | 1 |
negative | expressions | 1 |
early | antibody | 1 |
early | expression | 1 |
early | gene | 1 |
early | study | 1 |
first | analysis | 1 |
first | antibody | 1 |
first | assayed | 1 |
first | cells | 1 |
first | ev | 1 |
first | infection | 1 |
first | method | 1 |
first | samples | 1 |
first | studied | 1 |
first | studies | 1 |
first | tested | 1 |
first | virus | 1 |
healthy | antibody | 1 |
healthy | mouse | 1 |
healthy | sample | 1 |
healthy | virus | 1 |
high | antibodies | 1 |
high | cell | 1 |
high | control | 1 |
high | effect | 1 |
high | gene | 1 |
high | p | 1 |
high | responses | 1 |
earliest | time | 1 |
earlier | results | 1 |
earlier | infection | 1 |
clinical | assay | 1 |
- | assayed | 1 |
- | controlling | 1 |
- | grouping | 1 |
- | methods | 1 |
- | sampled | 1 |
- | timed | 1 |
acute | effect | 1 |
acute | time | 1 |
acute | treatment | 1 |
anti | mouse | 1 |
anti | serum | 1 |
clinical | analyses | 1 |
clinical | controls | 1 |
different | studys | 1 |
clinical | diseases | 1 |
clinical | ev | 1 |
clinical | groups | 1 |
clinical | infections | 1 |
clinical | test | 1 |
clinical | tests | 1 |
different | analyses | 1 |
different | assay | 1 |
different | control | 1 |
different | effect | 1 |
different | group | 1 |
different | result | 1 |
high | sample | 1 |
higher | % | 1 |
higher | antibodies | 1 |
lowest | cell | 1 |
low | antibodies | 1 |
low | assay | 1 |
low | controls | 1 |
low | infection | 1 |
low | responses | 1 |
low | samples | 1 |
low | treatment | 1 |
lower | control | 1 |
lower | effect | 1 |
lower | response | 1 |
lower | time | 1 |
lowest | antibody | 1 |
lowest | effects | 1 |
inflammatory | mouse | 1 |
lowest | infection | 1 |
lowest | sample | 1 |
lowest | serum | 1 |
lowest | virus | 1 |
molecular | controls | 1 |
molecular | disease | 1 |
molecular | effects | 1 |
molecular | proteins | 1 |
molecular | response | 1 |
molecular | results | 1 |
molecular | treatment | 1 |
negative | ev | 1 |
inflammatory | treatment | 1 |
inflammatory | expression | 1 |
higher | assay | 1 |
human | level | 1 |
higher | cell | 1 |
higher | disease | 1 |
higher | infection | 1 |
higher | response | 1 |
higher | sample | 1 |
higher | test | 1 |
highest | % | 1 |
highest | cell | 1 |
highest | effect | 1 |
highest | elisa | 1 |
highest | protein | 1 |
highest | samples | 1 |
human | levels | 1 |
inflammatory | evs | 1 |
human | response | 1 |
humans | effects | 1 |
immune | antibodies | 1 |
immune | disease | 1 |
immune | ev | 1 |
immune | levels | 1 |
immune | responsing | 1 |
important | control | 1 |
important | method | 1 |
important | result | 1 |
important | test | 1 |
inflammatory | assays | 1 |
viral | response | 1 |